Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Altered Brain Uptake of Therapeutics in a Triple Transgenic Mouse Model of Alzheimer’s Disease
Authors
Keywords
Alzheimer’s disease, blood–brain barrier, cerebrovascular basement membrane, <em class=EmphasisTypeItalic >in situ</em> transcardiac perfusion, P-glycoprotein, triple transgenic
Journal
PHARMACEUTICAL RESEARCH
Volume 30, Issue 11, Pages 2868-2879
Publisher
Springer Nature
Online
2013-06-22
DOI
10.1007/s11095-013-1116-2
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Confounding Parameters in Preclinical Assessment of Blood–Brain Barrier Permeation: An Overview With Emphasis on Species Differences and Effect of Disease States
- (2012) Anand K. Deo et al. MOLECULAR PHARMACEUTICS
- Loss of functional GABAA receptors in the Alzheimer diseased brain
- (2012) A. Limon et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Drug delivery to the brain in Alzheimer's disease: Consideration of the blood–brain barrier
- (2011) William A. Banks ADVANCED DRUG DELIVERY REVIEWS
- Dendritic Degeneration, Neurovascular Defects, and Inflammation Precede Neuronal Loss in a Mouse Model for Tau-Mediated Neurodegeneration
- (2011) Tomasz Jaworski et al. AMERICAN JOURNAL OF PATHOLOGY
- Beta amyloid effects on expression of multidrug efflux transporters in brain endothelial cells
- (2011) Katarzyna D. Kania et al. BRAIN RESEARCH
- Impact of P-Glycoprotein Inhibition and Lipopolysaccharide Administration on Blood-Brain Barrier Transport of Colistin in Mice
- (2010) Liang Jin et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Restoring Blood-Brain Barrier P-Glycoprotein Reduces Brain Amyloid- in a Mouse Model of Alzheimer's Disease
- (2010) A. M. S. Hartz et al. MOLECULAR PHARMACOLOGY
- Insulin detemir is not transported across the blood–brain barrier
- (2010) William A. Banks et al. PEPTIDES
- Reduction of the cerebrovascular volume in a transgenic mouse model of Alzheimer's disease
- (2009) Fanchon Bourasset et al. NEUROPHARMACOLOGY
- Assessment of Blood–Brain Barrier Permeability Using the In Situ Mouse Brain Perfusion Technique
- (2009) Rong Zhao et al. PHARMACEUTICAL RESEARCH
- Blood–brain barrier permeability in Alzheimer's disease: a case–control MRI study
- (2009) John M. Starr et al. PSYCHIATRY RESEARCH-NEUROIMAGING
- Chylomicron amyloid-beta in the aetiology of Alzheimer's disease
- (2008) R. Takechi et al. ATHEROSCLEROSIS SUPPLEMENTS
- In Situ Mouse Carotid Perfusion Model: Glucose and Cholesterol Transport in the Eye and Brain
- (2008) Julie Cattelotte et al. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM
- Soluble aggregates of the amyloid-β protein selectively stimulate permeability in human brain microvascular endothelial monolayers
- (2008) Francisco J. Gonzalez-Velasquez et al. JOURNAL OF NEUROCHEMISTRY
- Lipopolysaccharide Impairs Blood–Brain Barrier P-glycoprotein Function in Mice Through Prostaglandin- and Nitric Oxide-Independent Pathways
- (2008) Mohamad A. Salkeni et al. Journal of Neuroimmune Pharmacology
- Rapid Restoration of Cognition in Alzheimer's Transgenic Mice with 8-Hydroxy Quinoline Analogs Is Associated with Decreased Interstitial Aβ
- (2008) Paul A. Adlard et al. NEURON
- The Blood-Brain Barrier in Health and Chronic Neurodegenerative Disorders
- (2008) Berislav V. Zlokovic NEURON
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started